{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T22:14:49Z","timestamp":1771971289202,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11060-023-04485-2","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:01:48Z","timestamp":1698400908000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Metformin use is associated with longer survival in glioblastoma patients with MGMT gene silencing"],"prefix":"10.1007","volume":"165","author":[{"given":"Amro H.","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukhdeep","family":"Jatana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Ruiz-Barerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Al-Saadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto J.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,27]]},"reference":[{"issue":"Suppl 5","key":"4485_CR1","doi-asserted-by":"publisher","first-page":"v190","DOI":"10.1093\/annonc\/mdq187","volume":"21","author":"R Stupp","year":"2010","unstructured":"Stupp R, Tonn JC, Brada M, Pentheroudakis G, Group EGW (2010) High-grade malignant glioma: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v190\u2013v193. https:\/\/doi.org\/10.1093\/annonc\/mdq187","journal-title":"Ann Oncol"},{"issue":"12","key":"4485_CR2","doi-asserted-by":"publisher","first-page":"6242","DOI":"10.1073\/pnas.97.12.6242","volume":"97","author":"EC Holland","year":"2000","unstructured":"Holland EC (2000) Glioblastoma Multiforme: the terminator. Proc Natl Acad Sci U S A 97(12):6242\u20136244. https:\/\/doi.org\/10.1073\/pnas.97.12.6242","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"4485_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"issue":"5","key":"4485_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/neuonc\/nox209","volume":"20","author":"P Chinnaiyan","year":"2018","unstructured":"Chinnaiyan P, Won M, Wen PY et al (2018) A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913. Neuro Oncol 20(5):666\u2013673. https:\/\/doi.org\/10.1093\/neuonc\/nox209","journal-title":"Neuro Oncol"},{"issue":"8","key":"4485_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","volume":"370","author":"MR Gilbert","year":"2014","unstructured":"Gilbert MR, Dignam JJ, Armstrong TS et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370(8):699\u2013708. https:\/\/doi.org\/10.1056\/NEJMoa1308573","journal-title":"N Engl J Med"},{"issue":"1","key":"4485_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB et al (2009) Medical management of hyperglycemia in type 2 Diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the study of Diabetes. Diabetes Care 32(1):193\u2013203. https:\/\/doi.org\/10.2337\/dc08-9025","journal-title":"Diabetes Care"},{"key":"4485_CR7","doi-asserted-by":"crossref","unstructured":"Chan AT (2016) ;17(4):407-09 doi: 10.1016\/S1470-2045(16)00006-1 [published Online First: 20160303]","DOI":"10.1016\/S1470-2045(16)00006-1"},{"issue":"Pt 3","key":"4485_CR8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348(Pt 3):607\u2013614","journal-title":"Biochem J"},{"issue":"2","key":"4485_CR9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.3892\/mmr.2019.10369","volume":"20","author":"ZS Xiong","year":"2019","unstructured":"Xiong ZS, Gong SF, Si W et al (2019) Effect of metformin on cell proliferation, apoptosis, migration and invasion in A172 glioma cells and its mechanisms. Mol Med Rep 20(2):887\u2013894. https:\/\/doi.org\/10.3892\/mmr.2019.10369","journal-title":"Mol Med Rep"},{"issue":"4","key":"4485_CR10","doi-asserted-by":"publisher","first-page":"e0123721","DOI":"10.1371\/journal.pone.0123721","volume":"10","author":"J Sesen","year":"2015","unstructured":"Sesen J, Dahan P, Scotland SJ et al (2015) Metformin inhibits growth of human glioblastoma cells and enhances therapeutic response. PLoS ONE 10(4):e0123721. https:\/\/doi.org\/10.1371\/journal.pone.0123721","journal-title":"PLoS ONE"},{"issue":"68","key":"4485_CR11","doi-asserted-by":"publisher","first-page":"113090","DOI":"10.18632\/oncotarget.23028","volume":"8","author":"S Valtorta","year":"2017","unstructured":"Valtorta S, Lo Dico A, Raccagni I et al (2017) Metformin and temozolomide, a synergic option to overcome resistance in Glioblastoma Multiforme models. Oncotarget 8(68):113090\u2013113104. https:\/\/doi.org\/10.18632\/oncotarget.23028","journal-title":"Oncotarget"},{"issue":"4","key":"4485_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1515\/raon-2017-0042","volume":"51","author":"S Adeberg","year":"2017","unstructured":"Adeberg S, Bernhardt D, Harrabi SB et al (2017) Metformin Enhanced in Vitro Radiosensitivity Associates with G2\/M cell cycle arrest and elevated Adenosine-5\u2019-monophosphate-activated protein kinase levels in Glioblastoma. Radiol Oncol 51(4):431\u2013437. https:\/\/doi.org\/10.1515\/raon-2017-0042","journal-title":"Radiol Oncol"},{"issue":"9","key":"4485_CR13","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1002\/1097-0142(19840501)53:9%3C2002::aid-cncr2820530933%3E3.0.co;2-w","volume":"53","author":"V Mor","year":"1984","unstructured":"Mor V, Laliberte L, Morris JN, Wiemann M (1984) The Karnofsky Performance Status Scale. An examination of its reliability and validity in a research setting. Cancer 53(9):2002\u20132007. https:\/\/doi.org\/10.1002\/1097-0142(19840501)53:9%3C2002::aid-cncr2820530933%3E3.0.co;2-w","journal-title":"Cancer"},{"issue":"4","key":"4485_CR14","first-page":"793","volume":"59","author":"M Esteller","year":"1999","unstructured":"Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG (1999) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59(4):793\u2013797","journal-title":"Cancer Res"},{"issue":"1","key":"4485_CR15","doi-asserted-by":"publisher","first-page":"e16146","DOI":"10.1371\/journal.pone.0016146","volume":"6","author":"N Shah","year":"2011","unstructured":"Shah N, Lin B, Sibenaller Z et al (2011) Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM. PLoS ONE 6(1):e16146. https:\/\/doi.org\/10.1371\/journal.pone.0016146","journal-title":"PLoS ONE"},{"issue":"11","key":"4485_CR16","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1056\/NEJMoa1611977","volume":"376","author":"JR Perry","year":"2017","unstructured":"Perry JR, Laperriere N, O\u2019Callaghan CJ et al (2017) Short-course Radiation plus Temozolomide in Elderly patients with Glioblastoma. N Engl J Med 376(11):1027\u20131037. https:\/\/doi.org\/10.1056\/NEJMoa1611977","journal-title":"N Engl J Med"},{"issue":"10","key":"4485_CR17","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","volume":"352","author":"ME Hegi","year":"2005","unstructured":"Hegi ME, Diserens AC, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10):997\u20131003. https:\/\/doi.org\/10.1056\/NEJMoa043331","journal-title":"N Engl J Med"},{"issue":"3","key":"4485_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11060-012-0844-1","volume":"108","author":"TA Juratli","year":"2012","unstructured":"Juratli TA, Kirsch M, Robel K et al (2012) IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas. J Neurooncol 108(3):403\u2013410. https:\/\/doi.org\/10.1007\/s11060-012-0844-1","journal-title":"J Neurooncol"},{"issue":"20","key":"4485_CR19","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1158\/1078-0432.CCR-12-1773","volume":"18","author":"H Yang","year":"2012","unstructured":"Yang H, Ye D, Guan KL, Xiong Y (2012) IDH1 and IDH2 mutations in tumorigenesis: mechanistic insights and clinical perspectives. Clin Cancer Res 18(20):5562\u20135571. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-1773","journal-title":"Clin Cancer Res"},{"issue":"8","key":"4485_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8):765\u2013773. https:\/\/doi.org\/10.1056\/NEJMoa0808710","journal-title":"N Engl J Med"},{"issue":"5","key":"4485_CR21","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/s1734-1140(10)70357-1","volume":"62","author":"K Labuzek","year":"2010","unstructured":"Labuzek K, Suchy D, Gabryel B, Bielecka A, Liber S, Okopien B (2010) Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep 62(5):956\u2013965. https:\/\/doi.org\/10.1016\/s1734-1140(10)70357-1","journal-title":"Pharmacol Rep"},{"issue":"11","key":"4485_CR22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.5966\/sctm.2012-0058","volume":"1","author":"A Sato","year":"2012","unstructured":"Sato A, Sunayama J, Okada M et al (2012) Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK. Stem Cells Transl Med 1(11):811\u2013824. https:\/\/doi.org\/10.5966\/sctm.2012-0058","journal-title":"Stem Cells Transl Med"},{"key":"4485_CR23","doi-asserted-by":"publisher","unstructured":"Guarnaccia L, Navone SE, Masseroli MM et al (2022) Effects of Metformin as Add-On therapy against Glioblastoma: An Old Medicine for Novel Oncology therapeutics. Cancers (Basel) 14(6). https:\/\/doi.org\/10.3390\/cancers14061412","DOI":"10.3390\/cancers14061412"},{"key":"4485_CR24","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fonc.2019.00463","volume":"9","author":"A Lo Dico","year":"2019","unstructured":"Lo Dico A, Valtorta S, Ottobrini L, Moresco RM (2019) Role of Metformin and AKT Axis Modulation in the reversion of Hypoxia Induced TMZ-Resistance in Glioma cells. Front Oncol 9:463. https:\/\/doi.org\/10.3389\/fonc.2019.00463","journal-title":"Front Oncol"},{"issue":"2","key":"4485_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.tranon.2018.02.012","volume":"11","author":"YT Chang","year":"2018","unstructured":"Chang YT, Tsai HL, Kung YT et al (2018) Dose-dependent relationship between metformin and Colorectal Cancer occurrence among patients with type 2 Diabetes-A Nationwide Cohort Study. Transl Oncol 11(2):535\u2013541. https:\/\/doi.org\/10.1016\/j.tranon.2018.02.012","journal-title":"Transl Oncol"},{"issue":"5","key":"4485_CR26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/jnci\/djy144","volume":"111","author":"KS Cheung","year":"2019","unstructured":"Cheung KS, Chan EW, Wong AYS et al (2019) Metformin Use and Gastric Cancer Risk in Diabetic patients after Helicobacter pylori Eradication. J Natl Cancer Inst 111(5):484\u2013489. https:\/\/doi.org\/10.1093\/jnci\/djy144","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"4485_CR27","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S1470-2045(15)00027-3","volume":"16","author":"S Kordes","year":"2015","unstructured":"Kordes S, Pollak MN, Zwinderman AH et al (2015) Metformin in patients with advanced Pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial. Lancet Oncol 16(7):839\u2013847. https:\/\/doi.org\/10.1016\/S1470-2045(15)00027-3","journal-title":"Lancet Oncol"},{"key":"4485_CR28","doi-asserted-by":"publisher","unstructured":"Ohno M, Kitanaka C, Miyakita Y et al (2022) Metformin with Temozolomide for newly diagnosed Glioblastoma: results of phase I study and a brief review of relevant Studies. Cancers (Basel) 14(17). https:\/\/doi.org\/10.3390\/cancers14174222","DOI":"10.3390\/cancers14174222"},{"issue":"3","key":"4485_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22(3):659\u2013661. https:\/\/doi.org\/10.1096\/fj.07-9574LSF","journal-title":"FASEB J"},{"issue":"1","key":"4485_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11060-009-9990-5","volume":"97","author":"HJ Marcus","year":"2010","unstructured":"Marcus HJ, Carpenter KL, Price SJ, Hutchinson PJ (2010) In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines. J Neurooncol 97(1):11\u201323.","journal-title":"J Neurooncol"},{"issue":"3","key":"4485_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2217\/cns.13.12","volume":"2","author":"MR Welch","year":"2013","unstructured":"Welch MR, Grommes C (2013) Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients. CNS Oncol 2(3):237\u2013246. https:\/\/doi.org\/10.2217\/cns.13.12","journal-title":"CNS Oncol"},{"issue":"1","key":"4485_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/ANA.0000000000000339","volume":"29","author":"K Hagan","year":"2017","unstructured":"Hagan K, Bhavsar S, Arunkumar R et al (2017) Association between Perioperative Hyperglycemia and Survival in patients with Glioblastoma. J Neurosurg Anesthesiol 29(1):21\u201329. https:\/\/doi.org\/10.1097\/ANA.0000000000000339","journal-title":"J Neurosurg Anesthesiol"},{"issue":"1","key":"4485_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1086\/518580","volume":"45","author":"S McClelland","year":"2007","unstructured":"McClelland S 3rd, Hall WA (2007) Postoperative central nervous system Infection: incidence and associated factors in 2111 neurosurgical procedures. Clin Infect Dis 45(1):55\u201359. https:\/\/doi.org\/10.1086\/518580","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04485-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04485-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04485-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T11:11:43Z","timestamp":1699614703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04485-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["4485"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04485-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"25 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}